Search results for: 'rare partnering 2004 221b'
- Did you mean
- rate partnering 2004 221b
- Related search terms
- partnering agreementd with bigpharma
- partnering agreements with bigpharma
- Partnering Terms and Agreements in Diagnostics
- partnering interests of Amgen
- partnering agreements with optimer pharmaceutical 221b 221b
-
Ophthalmics Collaboration and Licensing Deals 2019-2024October 2024$3,995.00Ophthalmics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2024
Learn More -
Regenerative Medicine Collaboration and Licensing Deals 2016-2024May 2024$3,995.00Regenerative Medicine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Immunology Collaboration and Licensing Deals 2016-2024October 2024$3,995.00Immunology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Drug Delivery Collaboration and Licensing Deals 2016-2024May 2024$3,995.00Drug Delivery Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Cardiovascular Collaboration and Licensing Deals 2016-2024October 2024$3,995.00Cardiovascular Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Cancer Diagnostic Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Cancer Diagnostic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Oncology Collaboration and Licensing Deals 2019-2024October 2024$3,995.00Oncology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2024
Learn More -
Asset Purchase Deals in Pharmaceuticals, Biotechnology, Medical Devices and Diagnostics 2016 to 2024September 2024$3,995.00Asset Purchase Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More -
Licensing Deals in Pharmaceuticals 2019-2024September 2024$3,995.00Licensing Deals in Pharmaceuticals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2024
Learn More -
Royalty Rates in Pharmaceutical and Biotechnology DealsSeptember 2024$3,995.00Essential Benchmark Data for Dealmakers | Global coverage | Updated to 2024 | Over a decade of royalty rates | Deal financials | Contract documents | Royalty rate trends
Learn More
